These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11524705)

  • 21. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
    McDonald LC
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of vancomycin-susceptible and -resistant enterococci isolated in Italy from raw meat products, farm animals, and human infections.
    Busani L; Del Grosso M; Paladini C; Graziani C; Pantosti A; Biavasco F; Caprioli A
    Int J Food Microbiol; 2004 Dec; 97(1):17-22. PubMed ID: 15527914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
    Doern GV
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):821-35. PubMed ID: 17140358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on antimicrobial chemotherapy: 2. The mechanisms of antibiotic resistance.
    Smith A; Bagg J
    Dent Update; 1998 Jun; 25(5):203-4, 206-8. PubMed ID: 18170955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of antibacterial multidrug resistance.
    Alekshun MN; Levy SB
    Cell; 2007 Mar; 128(6):1037-50. PubMed ID: 17382878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational approach to limiting emergence of antimicrobial drug resistance.
    Mbori-Ngacha DA
    East Afr Med J; 1997 Mar; 74(3):187-9. PubMed ID: 9185420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enterococcal resistance--an overview.
    Marothi YA; Agnihotri H; Dubey D
    Indian J Med Microbiol; 2005 Oct; 23(4):214-9. PubMed ID: 16327115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
    Gilbert P; Allison DG; McBain AJ
    J Appl Microbiol; 2002; 92 Suppl():98S-110S. PubMed ID: 12000619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America).
    Kirby JT; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):75-82. PubMed ID: 16876375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The changing epidemiology of resistance.
    Hawkey PM; Jones AM
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i3-10. PubMed ID: 19675017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?
    Gilbert P; Allison DG; McBain AJ
    Symp Ser Soc Appl Microbiol; 2002; (31):98S-110S. PubMed ID: 12481835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?
    Lewis JS; Jorgensen JH
    Clin Infect Dis; 2005 Jan; 40(2):280-5. PubMed ID: 15655748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004).
    Rhomberg PR; Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2006 Apr; 54(4):249-57. PubMed ID: 16466890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
    Brown PD; Ngeno C
    Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial drug resistance in Taiwan.
    Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S174-8. PubMed ID: 19013350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).
    Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):207-15. PubMed ID: 16949243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.